[The influence of mecytosine on the antiblastic effect of radiation].
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000532:radiotherapy; D006528:Carcinoma, Hepatocellular / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D008113:Liver Neoplasms / Q000532:radiotherapy; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy; D008545:Melanoma / Q000532:radiotherapy; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000532:radiotherapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D012510:Sarcoma 180 / Q000532:radiotherapy; D012511:Sarcoma 37 / Q000532:radiotherapy; D012513:Sarcoma, Experimental / Q000532:radiotherapy
D011743:Pyrimidines; D011838:Radiation-Sensitizing Agents
Vliianie metsitozina na antiblastomnoe deistvie radiatsii.